ISONIAZID

ISONIAZID was reported 16327 times

ISONIAZID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 98 0.5385
1 SERPIGINOUS CHOROIDITIS 24 0.5000
2 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 163 0.4866
3 VAGINAL FLATULENCE 90 0.2970
4 TUBERCULOSIS OF EYE 18 0.2571
5 INTERFERON GAMMA RELEASE ASSAY POSITIVE 34 0.2073
6 TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM 55 0.2030
7 MENINGITIS TUBERCULOUS 92 0.1646
8 PYELONEPHRITIS FUNGAL 12 0.1622
9 DIAPHRAGMATIC INJURY 12 0.1622
10 PARADOXICAL DRUG REACTION 557 0.1512
11 DEMODICIDOSIS 13 0.1413
12 HAEMODILUTION 13 0.1313
13 NICOTINIC ACID DEFICIENCY 14 0.1261
14 TUBERCULOSIS SKIN TEST POSITIVE 10 0.1235
15 TUBERCULOSIS OF GENITOURINARY SYSTEM 11 0.1209
16 HEMIANOPIA HETERONYMOUS 10 0.1163
17 PERICARDITIS TUBERCULOUS 11 0.1100
18 TUBERCULOSIS GASTROINTESTINAL 34 0.1066
19 SIDEROBLASTIC ANAEMIA 14 0.1000
20 SPLENIC EMBOLISM 11 0.0957
21 ACID FAST BACILLI INFECTION 15 0.0932
22 IMMUNE RECONSTITUTION SYNDROME 116 0.0899
23 PERITONEAL TUBERCULOSIS 39 0.0888
24 CHOROIDITIS 33 0.0882
25 EXTRAPULMONARY TUBERCULOSIS 26 0.0881
26 INTESTINAL TUBERCULOSIS 15 0.0862
27 LYMPH NODE TUBERCULOSIS 61 0.0820
28 DISSEMINATED TUBERCULOSIS 208 0.0810
29 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 37 0.0792
30 CUTANEOUS TUBERCULOSIS 14 0.0769
31 TUBERCULOUS PLEURISY 35 0.0740
32 BONE TUBERCULOSIS 28 0.0731
33 THALASSAEMIA 12 0.0702
34 PULMONARY TUBERCULOSIS 289 0.0676
35 MYCOBACTERIUM KANSASII INFECTION 11 0.0671
36 HEPATIC HAEMATOMA 31 0.0654
37 GINGIVITIS ULCERATIVE 13 0.0605
38 CONGESTIVE HEPATOPATHY 26 0.0580
39 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 288 0.0577
40 BOVINE TUBERCULOSIS 21 0.0548
41 FEMALE GENITAL TRACT FISTULA 93 0.0544
42 MYCOBACTERIUM FORTUITUM INFECTION 10 0.0541
43 HEPATITIS B CORE ANTIBODY POSITIVE 20 0.0531
44 PANCREATITIS HAEMORRHAGIC 23 0.0496
45 INFECTIVE ANEURYSM 23 0.0465
46 TOXIC OPTIC NEUROPATHY 20 0.0461
47 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 10 0.0452
48 VITAMIN B1 DECREASED 11 0.0438
49 OEDEMATOUS KIDNEY 11 0.0415
50 LATENT TUBERCULOSIS 84 0.0401
51 URINARY TRACT INFLAMMATION 14 0.0389
52 DANDY-WALKER SYNDROME 10 0.0386
53 CEREBELLAR ATAXIA 36 0.0376
54 HERPES ZOSTER MENINGOENCEPHALITIS 13 0.0361
55 RADICULOPATHY 93 0.0353
56 PAPILLOMA 11 0.0347
57 GRANULOMATOUS LIVER DISEASE 24 0.0341
58 HEPATITIS TOXIC 86 0.0330
59 MYCOBACTERIAL INFECTION 56 0.0325
60 THALAMIC INFARCTION 19 0.0320
61 PROCTITIS 89 0.0317
62 CONDUCTIVE DEAFNESS 10 0.0312
63 LOSS OF EMPLOYMENT 91 0.0301
64 TUBERCULIN TEST POSITIVE 76 0.0300
65 SPLENIC ABSCESS 12 0.0295
66 RENAL TRANSPLANT FAILURE 29 0.0294
67 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 753 0.0292
68 ACCELERATED HYPERTENSION 11 0.0290
69 DRUG-INDUCED LIVER INJURY 870 0.0277
70 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 33 0.0275
71 OEDEMATOUS PANCREATITIS 15 0.0267
72 JARISCH-HERXHEIMER REACTION 19 0.0267
73 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 63 0.0265
74 CHRONIC SINUSITIS 97 0.0258
75 CENTRAL NERVOUS SYSTEM VASCULITIS 13 0.0255
76 DISSEMINATED MUCORMYCOSIS 10 0.0254
77 MYCOBACTERIUM ABSCESSUS INFECTION 18 0.0252
78 ANTIPSYCHOTIC DRUG LEVEL DECREASED 13 0.0245
79 MULTIPLE-DRUG RESISTANCE 75 0.0242
80 KAPOSI'S SARCOMA 12 0.0239
81 HEPATOTOXICITY 510 0.0229
82 HYPERMETABOLISM 12 0.0226
83 OPTIC NEUROPATHY 47 0.0222
84 GLOMERULONEPHRITIS MINIMAL LESION 16 0.0220
85 MARROW HYPERPLASIA 15 0.0220
86 COMA HEPATIC 16 0.0216
87 TYPE III IMMUNE COMPLEX MEDIATED REACTION 12 0.0215
88 DELAYED GRAFT FUNCTION 15 0.0211
89 ACUTE HEPATIC FAILURE 285 0.0208
90 GRANULOMA 71 0.0205
91 STRONGYLOIDIASIS 32 0.0198
92 LYMPHOCYTE STIMULATION TEST POSITIVE 15 0.0187
93 FOCAL DYSCOGNITIVE SEIZURES 21 0.0184
94 PULMONARY GRANULOMA 21 0.0184
95 COMPLICATIONS OF TRANSPLANTED KIDNEY 41 0.0181
96 DRUG RESISTANCE 464 0.0180
97 PSOAS ABSCESS 11 0.0177
98 PNEUMOCYSTIS JIROVECI PNEUMONIA 39 0.0175
99 MICROCYTIC ANAEMIA 36 0.0173
100 OPTIC ATROPHY 28 0.0172
101 HEPATITIS FULMINANT 51 0.0172
102 HILAR LYMPHADENOPATHY 15 0.0170
103 LIVER TRANSPLANT REJECTION 30 0.0167
104 HEPATIC ENCEPHALOPATHY 153 0.0164
105 CEREBRAL TOXOPLASMOSIS 15 0.0161
106 ARACHNOIDITIS 11 0.0159
107 ERYTHRODERMIC PSORIASIS 13 0.0158
108 CHORIORETINITIS 10 0.0155
109 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 17 0.0155
110 OCULAR TOXICITY 17 0.0154
111 HYDROCEPHALUS 81 0.0149
112 PNEUMONIA CRYPTOCOCCAL 14 0.0148
113 ENTEROVESICAL FISTULA 11 0.0145
114 ANAEMIA OF CHRONIC DISEASE 13 0.0144
115 JAUNDICE 387 0.0144
116 CHOLESTATIC LIVER INJURY 32 0.0144
117 HEPATITIS 365 0.0143
118 COLOUR BLINDNESS 13 0.0141
119 CHRONIC ALLOGRAFT NEPHROPATHY 11 0.0140
120 HYPERURICAEMIA 57 0.0139
121 ADRENOCORTICAL INSUFFICIENCY ACUTE 27 0.0138
122 ACINETOBACTER INFECTION 15 0.0137
123 BILIRUBIN CONJUGATED INCREASED 31 0.0133
124 HEPATOSPLENOMEGALY 34 0.0132
125 LYMPHADENITIS 32 0.0132
126 HEPATIC NECROSIS 49 0.0130
127 LICHENOID KERATOSIS 29 0.0127
128 HYPERTRANSAMINASAEMIA 87 0.0125
129 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 11 0.0124
130 CRYPTOCOCCOSIS 20 0.0123
131 OTOTOXICITY 22 0.0119
132 DRUG LEVEL DECREASED 118 0.0116
133 ORAL CANDIDIASIS 152 0.0115
134 ABDOMINAL LYMPHADENOPATHY 10 0.0115
135 ATYPICAL MYCOBACTERIAL INFECTION 16 0.0113
136 HEPATITIS CHOLESTATIC 68 0.0113
137 CEREBRAL VENTRICLE DILATATION 13 0.0113
138 RENAL ATROPHY 14 0.0112
139 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 25 0.0112
140 NEUROPSYCHIATRIC SYMPTOMS 10 0.0111
141 LYMPHADENOPATHY MEDIASTINAL 21 0.0110
142 LIVER TRANSPLANT 39 0.0107
143 DISTRIBUTIVE SHOCK 24 0.0106
144 ENCEPHALITIS 73 0.0105
145 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 34 0.0105
146 MENINGITIS CRYPTOCOCCAL 18 0.0103
147 MYCOBACTERIUM AVIUM COMPLEX INFECTION 27 0.0100
148 BLOOD BICARBONATE DECREASED 19 0.0100
149 HEPATIC CYST 33 0.0097
150 HEPATIC STEATOSIS 180 0.0097
151 TRISOMY 21 12 0.0095
152 VAGINAL DISCHARGE 96 0.0095
153 SYSTEMIC MYCOSIS 11 0.0094
154 RESPIRATORY ALKALOSIS 15 0.0092
155 PATHOGEN RESISTANCE 84 0.0092
156 HENOCH-SCHONLEIN PURPURA 20 0.0091
157 CACHEXIA 47 0.0091
158 GRANULOMATOSIS WITH POLYANGIITIS 11 0.0091
159 APLASIA PURE RED CELL 31 0.0090
160 TRANSAMINASES INCREASED 200 0.0090
161 LABELLED DRUG-DRUG INTERACTION ISSUE 13 0.0090
162 EOSINOPHILIA 157 0.0090
163 BLOOD HIV RNA INCREASED 16 0.0088
164 OSTEOLYSIS 18 0.0088
165 INFECTIOUS PLEURAL EFFUSION 13 0.0085
166 INCISION SITE PAIN 10 0.0085
167 PSEUDOMEMBRANOUS COLITIS 19 0.0085
168 OPTIC NEURITIS 77 0.0085
169 CD4 LYMPHOCYTES DECREASED 18 0.0084
170 TRANSPLANT DYSFUNCTION 15 0.0084
171 FUNGAEMIA 13 0.0083
172 LUNG CONSOLIDATION 23 0.0082
173 NOCARDIOSIS 21 0.0082
174 CYTOMEGALOVIRUS CHORIORETINITIS 16 0.0082
175 VASCULAR PSEUDOANEURYSM 14 0.0080
176 SPLENIC INFARCTION 14 0.0080
177 ESCHERICHIA URINARY TRACT INFECTION 34 0.0080
178 RASH MORBILLIFORM 22 0.0079
179 HYPERSENSITIVITY VASCULITIS 20 0.0076
180 OCULAR ICTERUS 33 0.0076
181 HEPATIC FAILURE 229 0.0076
182 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 57 0.0076
183 ENCEPHALOPATHY 186 0.0076
184 OESOPHAGEAL CANDIDIASIS 30 0.0075
185 ASPERGILLUS INFECTION 48 0.0073
186 LIVER INJURY 179 0.0073
187 HEPATITIS ACUTE 47 0.0072
188 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 11 0.0072
189 TRANSPLANT REJECTION 57 0.0071
190 GAZE PALSY 12 0.0070
191 HIV INFECTION 21 0.0070
192 HYPERBILIRUBINAEMIA 72 0.0069
193 BILE DUCT OBSTRUCTION 13 0.0068
194 BLOOD PRESSURE DIASTOLIC ABNORMAL 17 0.0067
195 PARAESTHESIA ORAL 96 0.0066
196 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 22 0.0066
197 HEPATOMEGALY 65 0.0066
198 CHEST X-RAY ABNORMAL 20 0.0065
199 DISSEMINATED INTRAVASCULAR COAGULATION 91 0.0065
200 LYMPHADENOPATHY 228 0.0064
201 HISTIOCYTOSIS HAEMATOPHAGIC 19 0.0064
202 DERMATITIS EXFOLIATIVE 32 0.0064
203 MACULAR DEGENERATION 76 0.0064
204 RASH MACULO-PAPULAR 140 0.0063
205 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 10 0.0062
206 TYPE IV HYPERSENSITIVITY REACTION 17 0.0062
207 PROTHROMBIN TIME PROLONGED 37 0.0062
208 COMPUTERISED TOMOGRAM ABNORMAL 14 0.0062
209 PNEUMONIA CYTOMEGALOVIRAL 12 0.0062
210 MUCORMYCOSIS 16 0.0062
211 LEUKOCYTOCLASTIC VASCULITIS 10 0.0061
212 IMMUNE SYSTEM DISORDER 81 0.0061
213 AUTOIMMUNE HAEMOLYTIC ANAEMIA 21 0.0061
214 DRUG INTERACTION 967 0.0061
215 LIVER FUNCTION TEST ABNORMAL 176 0.0060
216 EMPYEMA 12 0.0060
217 VACCINATION FAILURE 10 0.0060
218 TYPE I HYPERSENSITIVITY 21 0.0060
219 NECROSIS 33 0.0059
220 PLEURISY 35 0.0059
221 HEPATIC FUNCTION ABNORMAL 218 0.0058
222 MENINGITIS 39 0.0058
223 TOXIC EPIDERMAL NECROLYSIS 86 0.0057
224 MYOCARDITIS 64 0.0056
225 HEPATIC CYTOLYSIS 71 0.0056
226 ALANINE AMINOTRANSFERASE INCREASED 340 0.0055
227 DERMATITIS EXFOLIATIVE GENERALISED 19 0.0055
228 COAGULOPATHY 91 0.0055
229 ASPARTATE AMINOTRANSFERASE INCREASED 290 0.0055
230 LIVER DISORDER 241 0.0054
231 DRUG ERUPTION 96 0.0054
232 OPPORTUNISTIC INFECTION 10 0.0054
233 LUNG INFILTRATION 47 0.0053
234 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 13 0.0053
235 HYPOREFLEXIA 10 0.0052
236 RENAL TUBULAR NECROSIS 51 0.0052
237 GENERALISED TONIC-CLONIC SEIZURE 85 0.0051
238 BLOOD BILIRUBIN INCREASED 138 0.0051
239 FACE OEDEMA 86 0.0051
240 DRUG LEVEL BELOW THERAPEUTIC 28 0.0051
241 MACULE 14 0.0050
242 CELL DEATH 10 0.0050
243 CREPITATIONS 15 0.0050
244 INTRACRANIAL PRESSURE INCREASED 28 0.0050
245 TUBULOINTERSTITIAL NEPHRITIS 94 0.0050
246 PSEUDOMONAS INFECTION 43 0.0050
247 MIXED LIVER INJURY 15 0.0050
248 STILLBIRTH 24 0.0050
249 SPLENOMEGALY 58 0.0049
250 CYTOMEGALOVIRUS VIRAEMIA 22 0.0049
251 AREFLEXIA 13 0.0049
252 HEPATOCELLULAR INJURY 69 0.0049
253 ADENOVIRUS INFECTION 14 0.0048
254 RENAL CYST 38 0.0048
255 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 37 0.0048
256 IRIDOCYCLITIS 15 0.0047
257 KLEBSIELLA INFECTION 24 0.0047
258 BRAIN ABSCESS 12 0.0047
259 IMPLANT SITE INFECTION 11 0.0047
260 DYSLIPIDAEMIA 24 0.0047
261 BLOOD URIC ACID INCREASED 27 0.0047
262 OCULOGYRIC CRISIS 10 0.0047
263 LOW BIRTH WEIGHT BABY 37 0.0047
264 PANCREATITIS CHRONIC 11 0.0046
265 VASCULITIS 54 0.0046
266 ABDOMINAL TENDERNESS 23 0.0046
267 LIVER ABSCESS 15 0.0046
268 NEUROTOXICITY 81 0.0046
269 ANTINUCLEAR ANTIBODY POSITIVE 15 0.0046
270 HYPERREFLEXIA 16 0.0046
271 IMMUNE THROMBOCYTOPENIA 21 0.0046
272 KIDNEY TRANSPLANT REJECTION 22 0.0046
273 PERICARDIAL EFFUSION 106 0.0046
274 DEAFNESS NEUROSENSORY 15 0.0046
275 THROMBOTIC THROMBOCYTOPENIC PURPURA 16 0.0045
276 TOXIC ENCEPHALOPATHY 23 0.0045
277 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 40 0.0045
278 NEPHROTIC SYNDROME 31 0.0045
279 BRONCHOPULMONARY ASPERGILLOSIS 35 0.0045
280 POLYNEUROPATHY 54 0.0045
281 GLOMERULONEPHRITIS 11 0.0045
282 BACTERIAL TEST POSITIVE 10 0.0045
283 HYPERLACTACIDAEMIA 12 0.0045
284 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 17 0.0044
285 ACUTE PSYCHOSIS 11 0.0044
286 LUPUS-LIKE SYNDROME 40 0.0044
287 STUPOR 14 0.0044
288 MULTIPLE ORGAN DYSFUNCTION SYNDROME 123 0.0043
289 HALLUCINATIONS, MIXED 18 0.0043
290 PURULENT DISCHARGE 18 0.0042
291 STEVENS-JOHNSON SYNDROME 93 0.0042
292 SUBCUTANEOUS ABSCESS 20 0.0042
293 LYMPHOPENIA 59 0.0042
294 HEPATIC ENZYME INCREASED 284 0.0042
295 CYTOMEGALOVIRUS INFECTION 69 0.0041
296 ENTEROCOCCAL INFECTION 20 0.0041
297 BRAIN OEDEMA 52 0.0041
298 PAPULE 29 0.0041
299 CARDIOPULMONARY FAILURE 16 0.0041
300 PULMONARY MASS 61 0.0041
301 PANCREATITIS ACUTE 92 0.0041
302 ACUTE RESPIRATORY DISTRESS SYNDROME 72 0.0041
303 BLOOD ALBUMIN DECREASED 32 0.0040
304 HAEMOLYTIC ANAEMIA 36 0.0040
305 PAPILLOEDEMA 18 0.0040
306 PNEUMOCYSTIS JIROVECII PNEUMONIA 40 0.0040
307 HEPATITIS B 24 0.0040
308 SERUM FERRITIN INCREASED 21 0.0040
309 HYPOVOLAEMIC SHOCK 19 0.0040
310 SEROTONIN SYNDROME 76 0.0040
311 PANCYTOPENIA 221 0.0040
312 VIROLOGIC FAILURE 21 0.0039
313 OLIGOHYDRAMNIOS 13 0.0039
314 OLIGURIA 24 0.0039
315 IMMUNOSUPPRESSION 34 0.0039
316 C-REACTIVE PROTEIN INCREASED 140 0.0038
317 WOUND DEHISCENCE 13 0.0038
318 PNEUMONIA BACTERIAL 35 0.0038
319 NYSTAGMUS 20 0.0038
320 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 19 0.0037
321 PURPURA 33 0.0037
322 METABOLIC ACIDOSIS 119 0.0037
323 MATERNAL EXPOSURE DURING BREAST FEEDING 15 0.0037
324 BRAIN HERNIATION 11 0.0037
325 FREQUENT BOWEL MOVEMENTS 99 0.0037
326 NORMOCHROMIC NORMOCYTIC ANAEMIA 11 0.0037
327 CONTRAINDICATED PRODUCT ADMINISTERED 110 0.0036
328 STATUS EPILEPTICUS 41 0.0036
329 BLOOD ALKALINE PHOSPHATASE INCREASED 90 0.0036
330 PLEURAL EFFUSION 220 0.0036
331 ASCITES 106 0.0036
332 PROCEDURAL PAIN 100 0.0036
333 CHOLESTASIS 68 0.0035
334 ERYTHEMA MULTIFORME 33 0.0035
335 GAMMA-GLUTAMYLTRANSFERASE INCREASED 78 0.0035
336 LUNG NEOPLASM 15 0.0035
337 GRAND MAL CONVULSION 32 0.0035
338 BACTERAEMIA 41 0.0035
339 FOETAL GROWTH RESTRICTION 21 0.0035
340 HAEMODIALYSIS 29 0.0034
341 COMA SCALE ABNORMAL 10 0.0034
342 SHOCK 79 0.0034
343 INFLAMMATORY MARKER INCREASED 17 0.0034
344 EXPOSURE DURING PREGNANCY 213 0.0034
345 HAEMODYNAMIC INSTABILITY 26 0.0034
346 BACTERIAL SEPSIS 11 0.0034
347 LEUKOCYTOSIS 61 0.0034
348 GASTROINTESTINAL PERFORATION 14 0.0034
349 CONJUNCTIVAL HYPERAEMIA 12 0.0034
350 CLOSTRIDIUM DIFFICILE COLITIS 35 0.0033
351 GASTROENTERITIS 48 0.0033
352 CUTANEOUS VASCULITIS 12 0.0033
353 PSYCHIATRIC SYMPTOM 24 0.0032
354 EOSINOPHIL COUNT INCREASED 27 0.0032
355 HERPES SIMPLEX 21 0.0032
356 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 33 0.0032
357 PYREXIA 1110 0.0032
358 DEMYELINATION 13 0.0032
359 RED BLOOD CELL SEDIMENTATION RATE INCREASED 35 0.0032
360 SKIN LESION 86 0.0031
361 COLITIS ULCERATIVE 140 0.0031
362 MALNUTRITION 35 0.0031
363 NEPHROPATHY TOXIC 35 0.0031
364 ENTEROCOLITIS 18 0.0031
365 ATAXIA 37 0.0031
366 ACUTE RESPIRATORY FAILURE 59 0.0031
367 POLYURIA 25 0.0030
368 BLOOD UREA INCREASED 51 0.0030
369 PNEUMOTHORAX 48 0.0030
370 ORGANISING PNEUMONIA 15 0.0030
371 CYTOLYTIC HEPATITIS 10 0.0030
372 AZOTAEMIA 12 0.0030
373 ATELECTASIS 29 0.0030
374 SKIN MASS 20 0.0030
375 GENERALISED OEDEMA 37 0.0030
376 LIVER FUNCTION TEST INCREASED 64 0.0030
377 PULMONARY TOXICITY 21 0.0030
378 AMMONIA INCREASED 15 0.0029
379 COLITIS 111 0.0029
380 HEPATIC FIBROSIS 10 0.0029
381 PUSTULAR PSORIASIS 10 0.0029
382 PROTEINURIA 55 0.0029
383 HEMIPARESIS 49 0.0029
384 MULTI-ORGAN FAILURE 50 0.0029
385 FINGER DEFORMITY 14 0.0029
386 RASH PUSTULAR 21 0.0029
387 INTERNATIONAL NORMALISED RATIO INCREASED 82 0.0029
388 UVEITIS 39 0.0029
389 PETECHIAE 30 0.0029
390 PULSELESS ELECTRICAL ACTIVITY 12 0.0029
391 TACHYPNOEA 39 0.0029
392 SEPTIC SHOCK 124 0.0028
393 DRUG LEVEL INCREASED 47 0.0028
394 INTERSTITIAL LUNG DISEASE 137 0.0028
395 HEPATIC ENZYME ABNORMAL 14 0.0028
396 PNEUMONIA FUNGAL 11 0.0028
397 POLYDIPSIA 11 0.0028
398 HEMIPLEGIA 23 0.0028
399 TREATMENT NONCOMPLIANCE 151 0.0028
400 RALES 16 0.0028
401 MOUTH ULCERATION 58 0.0027
402 THERAPEUTIC PRODUCT EFFECT DECREASED 123 0.0027
403 SKIN PAPILLOMA 11 0.0027
404 SARCOIDOSIS 13 0.0027
405 BLOOD LACTATE DEHYDROGENASE INCREASED 43 0.0027
406 PSYCHOTIC DISORDER 80 0.0027
407 CENTRAL NERVOUS SYSTEM LESION 37 0.0027
408 RESPIRATORY FAILURE 196 0.0027
409 RECTAL HAEMORRHAGE 115 0.0027
410 SKIN HYPERPIGMENTATION 23 0.0027
411 PULMONARY FIBROSIS 51 0.0027
412 CHROMATURIA 60 0.0027
413 THROMBOCYTOPENIA 296 0.0026
414 ANOREXIA 34 0.0026
415 BREATH SOUNDS ABNORMAL 13 0.0026
416 ABDOMINAL HERNIA 12 0.0026
417 ANAEMIA 501 0.0026
418 ACIDOSIS 20 0.0026
419 HERPES VIRUS INFECTION 15 0.0026
420 RESPIRATORY RATE INCREASED 23 0.0026
421 ALTERED STATE OF CONSCIOUSNESS 56 0.0026
422 TOXIC SKIN ERUPTION 26 0.0026
423 LEUKOPENIA 128 0.0026
424 MYOPATHY 22 0.0025
425 CEREBRAL INFARCTION 62 0.0025
426 LACTIC ACIDOSIS 82 0.0025
427 TONSILLITIS 13 0.0025
428 CHOLECYSTITIS ACUTE 14 0.0025
429 NEUTROPHILIA 14 0.0025
430 HAEMATOCHEZIA 135 0.0024
431 AUTOIMMUNE HEPATITIS 17 0.0024
432 HYPOALBUMINAEMIA 19 0.0024
433 NEUROPATHY PERIPHERAL 232 0.0024
434 BLOOD PRESSURE DIASTOLIC DECREASED 18 0.0024
435 ARTHRITIS BACTERIAL 10 0.0024
436 HYPERTENSIVE CRISIS 27 0.0024
437 PYELONEPHRITIS 21 0.0024
438 MUCOUS STOOLS 12 0.0024
439 DRUG TOXICITY 33 0.0024
440 HYPOVOLAEMIA 14 0.0024
441 PREMATURE DELIVERY 38 0.0024
442 PEMPHIGOID 18 0.0024
443 HAEMOPTYSIS 66 0.0024
444 YELLOW SKIN 11 0.0023
445 ABSCESS LIMB 10 0.0023
446 CARDIAC TAMPONADE 11 0.0023
447 SKIN NECROSIS 12 0.0023
448 HEPATIC LESION 10 0.0023
449 INFUSION RELATED REACTION 153 0.0023
450 REBOUND EFFECT 26 0.0023
451 PREMATURE LABOUR 13 0.0023
452 APLASTIC ANAEMIA 12 0.0023
453 SKIN DISORDER 76 0.0023
454 CARDIAC FAILURE 182 0.0023
455 BLOOD CREATINE INCREASED 10 0.0023
456 ANAL ABSCESS 12 0.0022
457 DERMATITIS ALLERGIC 28 0.0022
458 PERIPHERAL SENSORY NEUROPATHY 13 0.0022
459 FISTULA 25 0.0022
460 VISUAL FIELD DEFECT 16 0.0022
461 PNEUMONITIS 60 0.0022
462 GASTROINTESTINAL DISORDER 197 0.0022
463 BLOOD PRESSURE SYSTOLIC DECREASED 10 0.0022
464 ESCHERICHIA INFECTION 18 0.0022
465 DRUG INTOLERANCE 211 0.0022
466 GASTRIC DISORDER 74 0.0022
467 TENDON DISORDER 14 0.0021
468 ENDOCARDITIS 11 0.0021
469 ACUTE PULMONARY OEDEMA 12 0.0021
470 ELECTROCARDIOGRAM QT PROLONGED 76 0.0021
471 CONCOMITANT DISEASE AGGRAVATED 13 0.0021
472 HYPERCALCAEMIA 26 0.0021
473 RESPIRATORY DISTRESS 58 0.0021
474 PARTIAL SEIZURES 11 0.0021
475 NEUROLOGICAL SYMPTOM 12 0.0021
476 PREMATURE BABY 63 0.0021
477 BLOOD LACTIC ACID INCREASED 11 0.0021
478 BLOOD PRESSURE FLUCTUATION 50 0.0021
479 HAEMOLYSIS 16 0.0021
480 PHARYNGOLARYNGEAL PAIN 11 0.0021
481 RHABDOMYOLYSIS 86 0.0021
482 ANKYLOSING SPONDYLITIS 27 0.0020
483 SINUS TACHYCARDIA 29 0.0020
484 CARDIAC FAILURE CONGESTIVE 164 0.0020
485 SKIN PLAQUE 17 0.0020
486 SMALL FOR DATES BABY 10 0.0020
487 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 19 0.0020
488 PULMONARY ALVEOLAR HAEMORRHAGE 11 0.0020
489 RENAL FAILURE ACUTE 83 0.0020
490 SEPSIS 218 0.0020
491 TOXICITY TO VARIOUS AGENTS 329 0.0019
492 MENTAL STATUS CHANGES 54 0.0019
493 PIGMENTATION DISORDER 12 0.0019
494 FAILURE TO THRIVE 10 0.0019
495 EPSTEIN-BARR VIRUS INFECTION 12 0.0019
496 PULMONARY HAEMORRHAGE 15 0.0019
497 HAEMATOCRIT DECREASED 38 0.0019
498 STAPHYLOCOCCAL INFECTION 63 0.0019
499 HYPERKALAEMIA 65 0.0019
500 DRUG SPECIFIC ANTIBODY PRESENT 12 0.0018
501 RENAL IMPAIRMENT 155 0.0018
502 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 131 0.0018
503 GOUT 33 0.0018
504 BLOOD CREATININE INCREASED 120 0.0018
505 CANDIDA INFECTION 31 0.0018
506 LIPASE INCREASED 14 0.0018
507 TREATMENT FAILURE 151 0.0018
508 APPENDICITIS 17 0.0018
509 PANCREATITIS 96 0.0018
510 FUNGAL INFECTION 60 0.0018
511 BLOOD PRESSURE SYSTOLIC INCREASED 35 0.0018
512 EMPHYSEMA 18 0.0018
513 RASH ERYTHEMATOUS 85 0.0018
514 CHOLANGITIS 11 0.0018
515 BONE MARROW FAILURE 36 0.0018
516 GENERALISED ERYTHEMA 10 0.0018
517 ANURIA 15 0.0017
518 VENTRICULAR EXTRASYSTOLES 18 0.0017
519 PERICARDITIS 29 0.0017
520 UPPER GASTROINTESTINAL HAEMORRHAGE 29 0.0017
521 NEPHROPATHY 16 0.0017
522 INTESTINAL PERFORATION 19 0.0017
523 ACUTE CORONARY SYNDROME 14 0.0017
524 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 10 0.0017
525 CONDITION AGGRAVATED 511 0.0017
526 IMMUNODEFICIENCY 25 0.0017
527 DELIRIUM 58 0.0017
528 COMA 79 0.0017
529 OXYGEN SATURATION DECREASED 93 0.0017
530 NEUTROPENIA 224 0.0016
531 FACIAL PARALYSIS 14 0.0016
532 ACUTE KIDNEY INJURY 249 0.0016
533 IRON DEFICIENCY ANAEMIA 15 0.0016
534 FOLLICULITIS 17 0.0016
535 HYPONATRAEMIA 91 0.0016
536 SENSORY LOSS 13 0.0016
537 PRODUCTIVE COUGH 77 0.0016
538 CARDIAC ARREST 133 0.0016
539 PLATELET COUNT INCREASED 21 0.0016
540 GASTRITIS 42 0.0016
541 LUNG DISORDER 78 0.0016
542 SEIZURE 183 0.0016
543 LYMPHOCYTE COUNT DECREASED 28 0.0016
544 ABDOMINAL PAIN 364 0.0016
545 PRODUCT PRESCRIBING ISSUE 34 0.0016
546 HYPOKALAEMIA 72 0.0016
547 ELECTROLYTE IMBALANCE 18 0.0015
548 INTENTIONAL OVERDOSE 99 0.0015
549 HEPATIC CIRRHOSIS 29 0.0015
550 VISUAL ACUITY REDUCED 51 0.0015
551 REFUSAL OF TREATMENT BY PATIENT 10 0.0015
552 DERMATITIS BULLOUS 11 0.0015
553 ABDOMINAL PAIN UPPER 312 0.0015
554 DISEASE RECURRENCE 72 0.0015
555 THERAPY NON-RESPONDER 68 0.0015
556 DEPRESSED LEVEL OF CONSCIOUSNESS 59 0.0015
557 NIGHT SWEATS 48 0.0015
558 RHINITIS 12 0.0015
559 BLOOD SODIUM DECREASED 28 0.0015
560 HYPOGLYCAEMIA 72 0.0015
561 BRONCHIECTASIS 10 0.0015
562 ADRENAL INSUFFICIENCY 18 0.0015
563 LUNG INFECTION 23 0.0015
564 PULMONARY OEDEMA 66 0.0015
565 SUBARACHNOID HAEMORRHAGE 15 0.0015
566 PHARYNGITIS 18 0.0014
567 PERITONITIS 30 0.0014
568 DYSARTHRIA 54 0.0014
569 MASS 20 0.0014
570 FOETAL EXPOSURE DURING PREGNANCY 116 0.0014
571 DIPLOPIA 37 0.0014
572 HAEMATEMESIS 36 0.0014
573 HYPOXIA 50 0.0014
574 DUODENAL ULCER 10 0.0014
575 HYPERTENSION 300 0.0014
576 MUCOSAL INFLAMMATION 37 0.0014
577 OEDEMA PERIPHERAL 170 0.0014
578 BACTERIAL INFECTION 26 0.0014
579 CYTOPENIA 17 0.0014
580 HAEMATURIA 47 0.0014
581 CHOLELITHIASIS 45 0.0014
582 VOMITING 644 0.0014
583 SPINAL PAIN 16 0.0014
584 HAEMOGLOBIN DECREASED 140 0.0014
585 DYSPEPSIA 132 0.0013
586 SUICIDE ATTEMPT 81 0.0013
587 ARTHRALGIA 555 0.0013
588 SPINAL COMPRESSION FRACTURE 11 0.0013
589 ABSCESS 21 0.0013
590 COUGH 367 0.0013
591 TACHYCARDIA 116 0.0013
592 DIFFUSE LARGE B-CELL LYMPHOMA 10 0.0013
593 TENDONITIS 20 0.0013
594 ILEUS 16 0.0013
595 LETHARGY 74 0.0013
596 CARDIOMYOPATHY 19 0.0013
597 MANIA 21 0.0013
598 RASH GENERALISED 33 0.0013
599 VENTRICULAR TACHYCARDIA 21 0.0013
600 NEUROLEPTIC MALIGNANT SYNDROME 15 0.0013
601 DEAFNESS 33 0.0013
602 ERYTHEMA 259 0.0013
603 CHOLECYSTITIS 15 0.0013
604 PARALYSIS 18 0.0013
605 NAIL DISORDER 11 0.0013
606 HERPES ZOSTER 72 0.0013
607 GROIN PAIN 11 0.0013
608 WHITE BLOOD CELL COUNT INCREASED 48 0.0012
609 CELLULITIS 63 0.0012
610 MYELOSUPPRESSION 45 0.0012
611 BLOOD DISORDER 10 0.0012
612 GINGIVAL BLEEDING 17 0.0012
613 RASH PRURITIC 67 0.0012
614 NODULE 16 0.0012
615 RESPIRATORY DEPRESSION 15 0.0012
616 HYPOMAGNESAEMIA 17 0.0012
617 INTESTINAL OBSTRUCTION 46 0.0012
618 THERAPY PARTIAL RESPONDER 19 0.0012
619 ANHEDONIA 32 0.0012
620 ABDOMINAL DISCOMFORT 204 0.0012
621 PALLOR 33 0.0012
622 SKIN REACTION 17 0.0012
623 INFLAMMATION 62 0.0012
624 SKIN ULCER 31 0.0012
625 BLOOD THYROID STIMULATING HORMONE INCREASED 11 0.0012
626 CONVULSION 68 0.0012
627 OSTEOPENIA 18 0.0012
628 WEIGHT DECREASED 331 0.0012
629 HYPOTHERMIA 12 0.0012
630 MUSCLE ATROPHY 15 0.0012
631 RASH 516 0.0012
632 EYELID PTOSIS 12 0.0012
633 OEDEMA 64 0.0012
634 CHILLS 138 0.0012
635 GENERAL PHYSICAL HEALTH DETERIORATION 136 0.0012
636 VENTRICULAR FIBRILLATION 13 0.0012
637 RESPIRATORY DISORDER 35 0.0012
638 RASH PAPULAR 26 0.0012
639 RENAL FAILURE 154 0.0012
640 OSTEOMYELITIS 21 0.0012
641 BLINDNESS 47 0.0012
642 TENDERNESS 12 0.0012
643 NAUSEA 910 0.0011
644 MITRAL VALVE INCOMPETENCE 13 0.0011
645 OSTEOPOROSIS 47 0.0011
646 HYPERCHOLESTEROLAEMIA 11 0.0011
647 SPINAL OSTEOARTHRITIS 10 0.0011
648 CARDIOMEGALY 14 0.0011
649 AUTOIMMUNE DISORDER 11 0.0011
650 ECONOMIC PROBLEM 17 0.0011
651 DECREASED APPETITE 260 0.0011
652 BLOOD CREATINE PHOSPHOKINASE INCREASED 32 0.0011
653 HYPOCALCAEMIA 21 0.0011
654 PNEUMONIA 357 0.0011
655 CARDIO-RESPIRATORY ARREST 46 0.0011
656 PLATELET COUNT DECREASED 117 0.0011
657 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 60 0.0011
658 FOOT DEFORMITY 12 0.0011
659 MYALGIA 183 0.0011
660 COORDINATION ABNORMAL 15 0.0011
661 BLOOD CALCIUM DECREASED 12 0.0011
662 MALAISE 468 0.0011
663 BEDRIDDEN 14 0.0011
664 HYPOTHYROIDISM 34 0.0011
665 ARTERIOSCLEROSIS 10 0.0011
666 ABORTION INDUCED 10 0.0011
667 TOOTH INFECTION 14 0.0011
668 DISORIENTATION 42 0.0011
669 SMALL INTESTINAL OBSTRUCTION 13 0.0011
670 WHITE BLOOD CELL COUNT DECREASED 114 0.0011
671 ANAPHYLACTIC SHOCK 27 0.0010
672 BLOOD POTASSIUM DECREASED 31 0.0010
673 NERVOUS SYSTEM DISORDER 32 0.0010
674 CONJUNCTIVITIS 19 0.0010
675 CYANOSIS 16 0.0010
676 PRURITUS GENERALISED 22 0.0010
677 MYDRIASIS 13 0.0010
678 MENTAL DISORDER 44 0.0010
679 METASTASES TO CENTRAL NERVOUS SYSTEM 13 0.0010
680 CLOSTRIDIUM DIFFICILE INFECTION 22 0.0010
681 UNRESPONSIVE TO STIMULI 26 0.0010
682 PRODUCT USE IN UNAPPROVED INDICATION 249 0.0010
683 MUSCULOSKELETAL STIFFNESS 88 0.0010
684 WOUND INFECTION 11 0.0010
685 PNEUMONIA ASPIRATION 25 0.0010
686 OFF LABEL USE 872 0.0010
687 CONFUSIONAL STATE 160 0.0010
688 HYPERGLYCAEMIA 36 0.0010
689 HEADACHE 618 0.0010
690 TOOTH ABSCESS 10 0.0010
691 BRONCHOSPASM 14 0.0010
692 HYPERSENSITIVITY 182 0.0010
693 BODY TEMPERATURE INCREASED 20 0.0010
694 EJECTION FRACTION DECREASED 15 0.0010
695 INJECTION SITE DISCOLOURATION 12 0.0010
696 LOSS OF CONSCIOUSNESS 123 0.0010
697 ANAPHYLACTIC REACTION 53 0.0010
698 POISONING 12 0.0010
699 FEBRILE NEUTROPENIA 63 0.0009
700 ACUTE MYOCARDIAL INFARCTION 28 0.0009
701 SUDDEN DEATH 10 0.0009
702 ATRIAL FIBRILLATION 92 0.0009
703 JOINT SWELLING 114 0.0009
704 HYPOPHAGIA 24 0.0009
705 END STAGE RENAL DISEASE 17 0.0009
706 VIRAL INFECTION 31 0.0009
707 HYPOTENSION 186 0.0009
708 HYPERLIPIDAEMIA 11 0.0009
709 AGRANULOCYTOSIS 17 0.0009
710 HEPATITIS C 11 0.0009
711 DEVICE RELATED INFECTION 14 0.0009
712 RED BLOOD CELL COUNT DECREASED 26 0.0009
713 UPPER RESPIRATORY TRACT INFECTION 42 0.0009
714 DEEP VEIN THROMBOSIS 59 0.0009
715 DERMATITIS 19 0.0009
716 DRUG INEFFECTIVE 1195 0.0009
717 CARDIOGENIC SHOCK 13 0.0009
718 LYMPHOMA 14 0.0009
719 PRODUCT USE ISSUE 167 0.0009
720 COMPLETED SUICIDE 74 0.0009
721 BLOOD PRESSURE DECREASED 59 0.0009
722 EPILEPSY 27 0.0009
723 SCAB 10 0.0009
724 MATERNAL EXPOSURE DURING PREGNANCY 78 0.0009
725 HAEMORRHOIDS 17 0.0009
726 AGITATION 64 0.0009
727 HAEMORRHAGE INTRACRANIAL 13 0.0009
728 DYSPNOEA 492 0.0009
729 HYPOAESTHESIA ORAL 13 0.0009
730 BLOOD POTASSIUM INCREASED 14 0.0009
731 RASH MACULAR 30 0.0009
732 RHEUMATOID ARTHRITIS 97 0.0009
733 ABDOMINAL DISTENSION 89 0.0009
734 PHOTOPHOBIA 16 0.0008
735 RESPIRATORY TRACT INFECTION 22 0.0008
736 MUSCULOSKELETAL CHEST PAIN 13 0.0008
737 ANGIOEDEMA 37 0.0008
738 RESPIRATORY ARREST 23 0.0008
739 ASTHENIA 313 0.0008
740 ABDOMINAL PAIN LOWER 21 0.0008
741 DIABETES MELLITUS 63 0.0008
742 HEART RATE DECREASED 29 0.0008
743 ABORTION SPONTANEOUS 33 0.0008
744 DYSPNOEA EXERTIONAL 31 0.0008
745 MELAENA 18 0.0008
746 ULCER 13 0.0008
747 INFLUENZA 91 0.0008
748 ARTHRITIS 64 0.0008
749 PARANOIA 14 0.0008
750 PSORIASIS 106 0.0008
751 NEUTROPHIL COUNT DECREASED 33 0.0008
752 MUSCULAR WEAKNESS 92 0.0008
753 ACTIVITIES OF DAILY LIVING IMPAIRED 16 0.0008
754 CYST 10 0.0008
755 BLISTER 45 0.0008
756 SECRETION DISCHARGE 10 0.0008
757 DISEASE PROGRESSION 94 0.0008
758 SKIN EXFOLIATION 67 0.0008
759 DIARRHOEA 511 0.0008
760 PHOTOSENSITIVITY REACTION 13 0.0008
761 BRONCHITIS 58 0.0008
762 SKIN DISCOLOURATION 36 0.0008
763 DEHYDRATION 104 0.0008
764 OSTEOARTHRITIS 33 0.0008
765 PRURITUS 299 0.0008
766 SEASONAL ALLERGY 11 0.0008
767 DIALYSIS 11 0.0008
768 CONSTIPATION 169 0.0008
769 HYPOAESTHESIA 115 0.0008
770 JOINT STIFFNESS 20 0.0008
771 IMPAIRED HEALING 25 0.0008
772 FLUID OVERLOAD 11 0.0008
773 HALLUCINATION, AUDITORY 12 0.0008
774 HEART RATE IRREGULAR 17 0.0008
775 DIABETIC KETOACIDOSIS 18 0.0007
776 SPINAL FRACTURE 15 0.0007
777 CYTOKINE RELEASE SYNDROME 15 0.0007
778 LABORATORY TEST ABNORMAL 22 0.0007
779 HYPOACUSIS 32 0.0007
780 URINARY INCONTINENCE 22 0.0007
781 GASTROINTESTINAL HAEMORRHAGE 62 0.0007
782 GASTRIC ULCER 14 0.0007
783 DYSURIA 27 0.0007
784 MULTIPLE FRACTURES 12 0.0007
785 NECK PAIN 40 0.0007
786 HALLUCINATION, VISUAL 15 0.0007
787 SOMNOLENCE 143 0.0007
788 RENAL DISORDER 33 0.0007
789 DELUSION 11 0.0007
790 CIRCULATORY COLLAPSE 12 0.0007
791 URTICARIA 118 0.0007
792 SYSTEMIC LUPUS ERYTHEMATOSUS 25 0.0007
793 UPPER LIMB FRACTURE 14 0.0007
794 CEREBRAL HAEMORRHAGE 25 0.0007
795 INTENTIONAL PRODUCT USE ISSUE 61 0.0007
796 APHASIA 21 0.0007
797 HYPOKINESIA 10 0.0007
798 LOCAL SWELLING 12 0.0007
799 HEART RATE INCREASED 68 0.0007
800 CHEST PAIN 127 0.0007
801 MOVEMENT DISORDER 22 0.0007
802 SYNCOPE 68 0.0007
803 ORAL HERPES 13 0.0007
804 PERIPHERAL SWELLING 102 0.0007
805 VISUAL IMPAIRMENT 82 0.0007
806 CATARACT 39 0.0007
807 PAIN 401 0.0007
808 DYSSTASIA 19 0.0007
809 INFECTION 94 0.0006
810 PREGNANCY 13 0.0006
811 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 19 0.0006
812 VISION BLURRED 89 0.0006
813 FAECES DISCOLOURED 14 0.0006
814 WOUND 18 0.0006
815 THERAPEUTIC RESPONSE DECREASED 39 0.0006
816 PSORIATIC ARTHROPATHY 26 0.0006
817 RENAL INJURY 19 0.0006
818 EYE PAIN 36 0.0006
819 PAIN IN EXTREMITY 187 0.0006
820 URINARY TRACT INFECTION 108 0.0006
821 FOOT FRACTURE 12 0.0006
822 MUSCULOSKELETAL PAIN 33 0.0006
823 COLD SWEAT 11 0.0006
824 SENSORY DISTURBANCE 10 0.0006
825 GAIT DISTURBANCE 119 0.0006
826 DIABETES MELLITUS INADEQUATE CONTROL 11 0.0006
827 LIMB DISCOMFORT 19 0.0006
828 KIDNEY INFECTION 12 0.0006
829 SYNOVITIS 11 0.0006
830 TINNITUS 28 0.0006
831 EYE DISORDER 20 0.0006
832 DIZZINESS 299 0.0006
833 GAIT INABILITY 20 0.0006
834 SWELLING 56 0.0006
835 PARAESTHESIA 93 0.0006
836 INJECTION SITE PRURITUS 39 0.0006
837 GYNAECOMASTIA 18 0.0006
838 PALPITATIONS 68 0.0006
839 CHRONIC KIDNEY DISEASE 44 0.0006
840 COGNITIVE DISORDER 27 0.0006
841 PRESYNCOPE 14 0.0006
842 FEELING COLD 16 0.0006
843 INFLUENZA LIKE ILLNESS 47 0.0006
844 BLOOD TRIGLYCERIDES INCREASED 10 0.0006
845 STOMATITIS 34 0.0006
846 MENORRHAGIA 11 0.0006
847 BACK PAIN 130 0.0006
848 DRUG EXPOSURE DURING PREGNANCY 19 0.0006
849 MOBILITY DECREASED 40 0.0006
850 CHEST DISCOMFORT 57 0.0006
851 GASTRIC CANCER 14 0.0006
852 TOOTHACHE 10 0.0006
853 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
854 RESTLESSNESS 20 0.0005
855 FATIGUE 424 0.0005
856 HYPERHIDROSIS 70 0.0005
857 BONE DENSITY DECREASED 17 0.0005
858 VERTIGO 33 0.0005
859 OROPHARYNGEAL PAIN 50 0.0005
860 LOCALISED INFECTION 13 0.0005
861 TREMOR 89 0.0005
862 HAEMORRHAGE 56 0.0005
863 ARRHYTHMIA 25 0.0005
864 SINUSITIS 54 0.0005
865 RHINORRHOEA 34 0.0005
866 ANGINA PECTORIS 15 0.0005
867 FEELING HOT 32 0.0005
868 FLUSHING 53 0.0005
869 FEAR 14 0.0005
870 BLOOD PRESSURE INCREASED 79 0.0005
871 PULMONARY EMBOLISM 49 0.0005
872 IRRITABILITY 31 0.0005
873 BLOOD CHOLESTEROL INCREASED 24 0.0005
874 OVERDOSE 111 0.0005
875 DYSPHONIA 30 0.0005
876 POOR QUALITY SLEEP 11 0.0005
877 DIVERTICULITIS 14 0.0005
878 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 26 0.0005
879 FEEDING DISORDER 10 0.0005
880 SWELLING FACE 32 0.0005
881 WEIGHT INCREASED 110 0.0005
882 BRADYCARDIA 26 0.0005
883 NASOPHARYNGITIS 90 0.0005
884 RIB FRACTURE 10 0.0005
885 ARTHROPATHY 27 0.0005
886 LOWER RESPIRATORY TRACT INFECTION 22 0.0005
887 PRODUCT AVAILABILITY ISSUE 11 0.0005
888 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 23 0.0005
889 ECZEMA 25 0.0005
890 SPEECH DISORDER 25 0.0005
891 CYSTITIS 15 0.0005
892 DEMENTIA 13 0.0005
893 ANXIETY 131 0.0005
894 INJECTION SITE ERYTHEMA 57 0.0005
895 POLLAKIURIA 19 0.0005
896 EPISTAXIS 34 0.0005
897 ABNORMAL BEHAVIOUR 18 0.0005
898 NEURALGIA 11 0.0005
899 DEPRESSION 102 0.0004
900 NASAL CONGESTION 26 0.0004
901 MOOD ALTERED 12 0.0004
902 HALLUCINATION 33 0.0004
903 DRUG EFFECT DECREASED 23 0.0004
904 OSTEONECROSIS 14 0.0004
905 INJECTION SITE RASH 13 0.0004
906 DYSKINESIA 17 0.0004
907 TYPE 2 DIABETES MELLITUS 14 0.0004
908 ALOPECIA 81 0.0004
909 SLEEP DISORDER 29 0.0004
910 HEAD INJURY 13 0.0004
911 LIMB INJURY 11 0.0004
912 ABASIA 10 0.0004
913 OCULAR HYPERAEMIA 19 0.0004
914 INSOMNIA 105 0.0004
915 NEPHROLITHIASIS 18 0.0004
916 INJECTION SITE SWELLING 30 0.0004
917 HAEMATOMA 10 0.0004
918 ACNE 29 0.0004
919 ADVERSE DRUG REACTION 34 0.0004
920 INJECTION SITE REACTION 26 0.0004
921 NIGHTMARE 13 0.0004
922 SUICIDAL IDEATION 34 0.0004
923 WHEEZING 22 0.0004
924 DISTURBANCE IN ATTENTION 20 0.0004
925 FLATULENCE 21 0.0004
926 FALL 123 0.0004
927 LUNG NEOPLASM MALIGNANT 15 0.0004
928 CORONARY ARTERY DISEASE 11 0.0004
929 DISCOMFORT 22 0.0004
930 LIP SWELLING 12 0.0004
931 URINARY RETENTION 12 0.0004
932 COVID-19 63 0.0004
933 WRONG TECHNIQUE IN DRUG USAGE PROCESS 13 0.0004
934 EMOTIONAL DISTRESS 42 0.0003
935 DRY EYE 17 0.0003
936 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 61 0.0003
937 BALANCE DISORDER 29 0.0003
938 MIGRAINE 32 0.0003
939 ROAD TRAFFIC ACCIDENT 14 0.0003
940 MYOCARDIAL INFARCTION 58 0.0003
941 DRUG EFFECT INCOMPLETE 12 0.0003
942 BURNING SENSATION 23 0.0003
943 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 23 0.0003
944 DEPRESSED MOOD 17 0.0003
945 ASTHMA 36 0.0003
946 DYSPHAGIA 30 0.0003
947 ILL-DEFINED DISORDER 19 0.0003
948 THERAPY CESSATION 16 0.0003
949 BONE PAIN 18 0.0003
950 MEDICATION ERROR 17 0.0003
951 BLOOD GLUCOSE INCREASED 57 0.0003
952 CONTUSION 29 0.0003
953 MUSCLE SPASMS 55 0.0003
954 HOSPITALISATION 46 0.0003
955 MEMORY IMPAIRMENT 41 0.0003
956 INTENTIONAL PRODUCT MISUSE 26 0.0003
957 EYE SWELLING 11 0.0003
958 INJECTION SITE HAEMORRHAGE 23 0.0003
959 DEATH 246 0.0003
960 HOT FLUSH 21 0.0003
961 FLUID RETENTION 14 0.0003
962 THROMBOSIS 22 0.0003
963 CEREBROVASCULAR ACCIDENT 46 0.0003
964 ADVERSE EVENT 25 0.0003
965 INJECTION SITE MASS 10 0.0003
966 INJECTION SITE PAIN 82 0.0003
967 INCORRECT DOSE ADMINISTERED 60 0.0003
968 ILLNESS 27 0.0003
969 AGGRESSION 13 0.0003
970 BLOOD GLUCOSE DECREASED 12 0.0002
971 AMNESIA 16 0.0002
972 CARDIAC DISORDER 23 0.0002
973 VAGINAL HAEMORRHAGE 10 0.0002
974 NERVOUSNESS 12 0.0002
975 FEELING ABNORMAL 55 0.0002
976 INJURY 16 0.0002
977 NEOPLASM MALIGNANT 15 0.0002
978 THROAT IRRITATION 10 0.0002
979 DEVICE MALFUNCTION 15 0.0002
980 INJECTION SITE BRUISING 17 0.0002
981 GASTROOESOPHAGEAL REFLUX DISEASE 17 0.0002
982 DYSGEUSIA 15 0.0002
983 DRY MOUTH 16 0.0002
984 DRY SKIN 26 0.0002
985 UNEVALUABLE EVENT 14 0.0002
986 SURGERY 10 0.0002
987 PRODUCT DOSE OMISSION 11 0.0002
988 THERAPY INTERRUPTED 12 0.0002
989 MALIGNANT NEOPLASM PROGRESSION 17 0.0002
990 DRUG DOSE OMISSION 25 0.0002
991 PRODUCT DOSE OMISSION ISSUE 40 0.0001
992 NO ADVERSE EVENT 17 0.0001
993 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 18 0.0001